copyright continues to be analyzed as monotherapy and in combination with metformin, metformin and sulfonylureas, metformin and/or thiazolidinedione, and basal insulin in sufferers with form 2 diabetes mellitus. A serious hypersensitivity response to semaglutide or to any with the excipients in copyright. Really serious hypersensitivity reaction